Cevec Pharmaceuticals

Provider of glyco-optimised human cell lines and gene therapy vectors using proprietary cell expression system

placeCologne, North Rhine Westphalia, Germany calendar_todayFounded 2001 groups39 employees language cevec.com

Registered entities

Innovation

24 patent families (13 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 755 times.

YearFilings
20154
20164
20173
20184
20195
20207
20216
20223
20236
20248
202510
20262

Investor mix

30 investors on record.

Investor typeCountShare
Venture capital310%
Other / undisclosed2790%
Coming soon